{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/hypercalcaemia/","result":{"data":{"firstChapter":{"id":"dfffab44-62c8-5590-8bad-e41f249a89e7","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field af27b454-2945-421a-99b8-ffd2e9122d6d --><h1>Hypercalcaemia: Summary</h1><!-- end field af27b454-2945-421a-99b8-ffd2e9122d6d -->","htmlStringContent":"<!-- begin item 726e9a91-c41f-42f1-bd7d-d9ee7a40c92c --><!-- begin field 0bcc0f55-0075-407a-8185-9a68211e1594 --><ul><li>Hypercalcaemia is defined as a serum calcium concentration of 2.6 mmol/L or higher, on two occasions, following adjustment (correction) for the serum albumin concentration.</li><li>Ranges of serum calcium concentration are used to classify the severity of hypercalcaemia:<ul><li>Mild hypercalcaemia is an adjusted serum calcium concentration of 2.6–3.00 mmol/L.</li><li>Moderate hypercalcaemia is an adjusted serum calcium concentration of 3.01–3.40 mmol/L.</li><li>Severe hypercalcaemia is an adjusted serum calcium concentration of greater than 3.40 mmol/L.</li></ul></li><li>There are multiple possible underlying causes of hypercalcaemia, the two most common being primary hyperparathyroidism and malignancy.<ul><li>Other possible causes include drugs, granulomatous diseases, renal disease, non-parathyroid endocrine diseases, familial hypocalciuric hypercalcaemia, and immobility.</li><li>Be aware that more than one underlying condition may co-exist.</li></ul></li><li>Consider a diagnosis of hypercalcaemia if:<ul><li>There is an incidental finding of a corrected serum calcium concentration of 2.6 mmol/L or higher on blood testing.</li><li>There are clinical features such as bone pain, osteoporosis, fatigue, confusion, memory problems, depression, nausea, vomiting, abdominal pain, weight loss, thirst, polyuria, constipation, abdominal pain, renal colic, or renal impairment. Symptoms and signs are often non-specific, and relate to the severity and rate of onset of hypercalcaemia.</li></ul></li><li>Confirmation of a diagnosis of hypercalcaemia requires:<ul><li>Checking a corrected serum calcium concentration and classifying the severity of hypercalcaemia.</li><li>If the person has severe hypercalcaemia or severe symptoms, emergency hospital admission should be arranged.</li><li>If the person is asymptomatic or has symptoms with mild or moderate hypercalcaemia, the corrected serum calcium concentration should be repeated to confirm the diagnosis.</li></ul></li><li>Assessment of a person with unexplained hypercalcaemia includes:<ul><li>Asking about clinical features, co-morbidities, family history, and drug treatments.</li><li>Assessing hydration status and for signs of an underlying cause.</li><li>Reviewing the duration and pattern of hypercalcaemia.</li><li>Arranging additional blood tests, urine tests, and chest X-ray to determine the underlying cause, depending on clinical judgement.</li></ul></li><li>Management of a person with unexplained hypercalcaemia includes:<ul><li>Arranging referral to an endocrinologist if primary hyperparathyroidism, familial hypocalciuric hypercalcaemia, or a non-parathyroid endocrine cause is suspected.</li><li>Arranging referral to an appropriate specialist if another underlying cause is suspected.</li><li>Reducing or stopping any potentially causative drugs and monitoring the response.</li></ul></li><li>Management of a person with hypercalcaemia of malignancy includes:<ul><li>Discussing with the person and/or carers whether management of hypercalcaemia is appropriate.</li><li>Liaising with the person's oncologist or palliative care specialist if there is any uncertainty about ongoing management.</li></ul></li><li>Follow-up of a person<strong> </strong>in primary care following specialist assessment involves:<ul><li>Providing advice on sources of information and support.</li><li>Monitoring for symptoms of hypercalcaemia.</li><li>Arranging monitoring of serum calcium, estimated glomerular filtration rate (eGFR) and creatinine, bone mineral density, and renal imaging, depending on specialist advice or clinical judgement.</li><li>Arranging referral to an endocrinologist or liaising with an oncologist or palliative care specialist if clinically indicated.</li><li>Offering advice on general lifestyle measures to reduce the risk of recurrent hypercalcaemia.</li></ul></li></ul><!-- end field 0bcc0f55-0075-407a-8185-9a68211e1594 --><!-- end item 726e9a91-c41f-42f1-bd7d-d9ee7a40c92c -->","topic":{"id":"c0ab4dd9-cccf-54af-a952-765aa048de1d","topicId":"897bf773-43ef-4092-a798-d9eb4cbcb9cc","topicName":"Hypercalcaemia","slug":"hypercalcaemia","aliases":[],"chapters":[{"id":"dfffab44-62c8-5590-8bad-e41f249a89e7","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"fbfb541d-eae2-5916-af42-b77d9c9ab401","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"3c7aba33-da1a-580a-b896-fb6026eb2ad8","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"61d715de-b85d-534b-8c6f-0cf5f59814c2","slug":"changes","fullItemName":"Changes"},{"id":"48c69505-e62a-5332-a3ad-fd44bb64bd34","slug":"update","fullItemName":"Update"}]},{"id":"0105d032-866a-57c0-8c83-2f54f2b7b491","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"989b5402-77d7-5cd9-86a7-979019eba917","slug":"goals","fullItemName":"Goals"},{"id":"5d8d7c84-01cb-59e9-a02e-489cb32e799e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e7c39bf4-b50f-51f7-ad27-49c431acf456","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1bb69f34-e184-554d-a518-e9d59c4f95de","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d7060151-5501-51fc-b393-844af2c2ca54","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7d4d8cad-82f7-5bb5-8c59-b47873b845b2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"4408b725-f01f-596c-b319-5ef7dd246c3c","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"28f41cc2-0513-5841-9fa6-1a59bb557452","slug":"definition","fullItemName":"Definition"},{"id":"b1dd3a7e-6be5-523b-a2c5-c41f9b364798","slug":"causes","fullItemName":"Causes"},{"id":"048198e1-607a-55c4-9d7d-a63135379c28","slug":"prevalence","fullItemName":"Prevalence"},{"id":"3c5e2134-d0b1-5804-bc33-86db97dfc33b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"62c64451-7e13-5be6-b868-01f8198a13ac","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"dc0291c2-c628-503e-a7f7-7f3fa1362b62","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"c5771a8e-2f1e-53ad-a2fc-322152fc3a3e","slug":"confirmation","fullItemName":"Confirmation"},{"id":"44ef7f17-c907-5252-8027-300e87635dc4","slug":"assessment","fullItemName":"Assessment"}]},{"id":"d005c3ba-c691-53c3-b23c-1c70928fb05d","slug":"management","fullItemName":"Management","subChapters":[{"id":"c604ea66-1be5-51cc-b014-9af770bbc709","slug":"unconfirmed-cause","fullItemName":"Scenario: Unconfirmed cause"},{"id":"4863d234-7059-57aa-b9cc-a51e3a1f3424","slug":"known-malignancy","fullItemName":"Scenario: Known malignancy"},{"id":"fb65182a-1069-5bbd-9c43-a547a8632cec","slug":"follow-up-in-primary-care","fullItemName":"Scenario: Follow-up in primary care"}]},{"id":"4017390d-3b38-5741-8d16-22624da35f3d","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"2ec3d6b5-1818-5b5f-af66-bd097d709bf2","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"847bb207-2cb8-5e5f-b3e8-ee87440a71cd","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"47a9d106-98da-5683-9641-88d123a8d071","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a8225b5a-40b4-53e5-9095-0953daa376fa","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c60f947f-6176-53b3-9484-54b966632a77","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b6a6af13-45f8-5258-a611-6d8306bbe251","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f68489fb-5d5f-5342-94a0-3979f632012b","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"c0ab4dd9-cccf-54af-a952-765aa048de1d","topicId":"897bf773-43ef-4092-a798-d9eb4cbcb9cc","topicName":"Hypercalcaemia","slug":"hypercalcaemia","aliases":[],"topicSummary":"Hypercalcaemia can be defined as a serum calcium concentration of 2.65 mmol/L (or higher) on two occasions","lastRevised":"Last revised in August 2019","nextPlannedReviewBy":"2024-08-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2024-07","nextPlannedReviewByDisplay":"July 2024","specialities":[{"id":"aa304738-44fc-5b1d-af3b-42cce5d27663","name":"Endocrine and metabolic","slug":"endocrine-metabolic"},{"id":"ad789c56-a29e-5319-92cd-223890d75f09","name":"Palliative care","slug":"palliative-care"}],"chapters":[{"id":"dfffab44-62c8-5590-8bad-e41f249a89e7","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"fbfb541d-eae2-5916-af42-b77d9c9ab401","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"3c7aba33-da1a-580a-b896-fb6026eb2ad8","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"61d715de-b85d-534b-8c6f-0cf5f59814c2","slug":"changes","fullItemName":"Changes"},{"id":"48c69505-e62a-5332-a3ad-fd44bb64bd34","slug":"update","fullItemName":"Update"}]},{"id":"0105d032-866a-57c0-8c83-2f54f2b7b491","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"989b5402-77d7-5cd9-86a7-979019eba917","slug":"goals","fullItemName":"Goals"},{"id":"5d8d7c84-01cb-59e9-a02e-489cb32e799e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e7c39bf4-b50f-51f7-ad27-49c431acf456","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1bb69f34-e184-554d-a518-e9d59c4f95de","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d7060151-5501-51fc-b393-844af2c2ca54","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7d4d8cad-82f7-5bb5-8c59-b47873b845b2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"4408b725-f01f-596c-b319-5ef7dd246c3c","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"28f41cc2-0513-5841-9fa6-1a59bb557452","slug":"definition","fullItemName":"Definition"},{"id":"b1dd3a7e-6be5-523b-a2c5-c41f9b364798","slug":"causes","fullItemName":"Causes"},{"id":"048198e1-607a-55c4-9d7d-a63135379c28","slug":"prevalence","fullItemName":"Prevalence"},{"id":"3c5e2134-d0b1-5804-bc33-86db97dfc33b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"62c64451-7e13-5be6-b868-01f8198a13ac","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"dc0291c2-c628-503e-a7f7-7f3fa1362b62","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"c5771a8e-2f1e-53ad-a2fc-322152fc3a3e","slug":"confirmation","fullItemName":"Confirmation"},{"id":"44ef7f17-c907-5252-8027-300e87635dc4","slug":"assessment","fullItemName":"Assessment"}]},{"id":"d005c3ba-c691-53c3-b23c-1c70928fb05d","slug":"management","fullItemName":"Management","subChapters":[{"id":"c604ea66-1be5-51cc-b014-9af770bbc709","slug":"unconfirmed-cause","fullItemName":"Scenario: Unconfirmed cause"},{"id":"4863d234-7059-57aa-b9cc-a51e3a1f3424","slug":"known-malignancy","fullItemName":"Scenario: Known malignancy"},{"id":"fb65182a-1069-5bbd-9c43-a547a8632cec","slug":"follow-up-in-primary-care","fullItemName":"Scenario: Follow-up in primary care"}]},{"id":"4017390d-3b38-5741-8d16-22624da35f3d","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"2ec3d6b5-1818-5b5f-af66-bd097d709bf2","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"847bb207-2cb8-5e5f-b3e8-ee87440a71cd","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"47a9d106-98da-5683-9641-88d123a8d071","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a8225b5a-40b4-53e5-9095-0953daa376fa","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c60f947f-6176-53b3-9484-54b966632a77","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b6a6af13-45f8-5258-a611-6d8306bbe251","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f68489fb-5d5f-5342-94a0-3979f632012b","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"c0ab4dd9-cccf-54af-a952-765aa048de1d"}},"staticQueryHashes":["3666801979"]}